Potential Circulating Biomarkers for Abdominal Aortic Aneurysm Expansion and Rupture - a Systematic Review

European Journal of Vascular and Endovascular Surgery

Volumn 36, Issue 3, 2008, Pages 273-280

  Urbonavicius, S ^a,b   Urbonaviciene, G ^a   Honore B ^b   Henneberg, E W ^a   Vorum, H ^b   Lindholt, J S ^a  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Abdominal aortics aneurysms; Circulating biomarkers; Expansion; Rupture

Indexed keywords

ANTIPLASMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CYSTATIN C; CYTOKINE; D DIMER; ELASTASE; ELASTIN; FIBRINOGEN; FIBRINOLYTIC FACTOR; GAMMA INTERFERON; GELATINASE A; GELATINASE B; HOMOCYSTEINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; OSTEOPONTIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANEURYSM SURGERY; AORTA SURGERY; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; DISEASE COURSE; DISEASE MARKER; EMBASE; HUMAN; INFLAMMATION; INFORMATION RETRIEVAL; MEDLINE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMATIC REVIEW;

ANTIPLASMIN; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ELASTIN; HUMANS; INTERFERON TYPE II; MATRIX METALLOPROTEINASE 9; PEPTIDES; PLASMIN; PREDICTIVE VALUE OF TESTS;

EID: 49349107741     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.05.009     Document Type: Review

References (44)

1. Schermerhorn M.L., and Cronenwett J.L. The UK small aneurysm trial. J Vasc Surg 33 2 (2001 Feb) 443
2. Lederle F.A., Johnson G.R., Wilson S.E., Ballard D.J., Jordan Jr. W.D., Blebea J., et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 287 22 (2002 Jun 12) 2968-2972
3. Cornuz J., Sidoti P.C., Tevaearai H., and Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health 14 4 (2004 Dec) 343-349
4. Lederle F.A., Johnson G.R., Wilson S.E., Chute E.P., Hye R.J., Makaroun M.S., et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 160 10 (2000 May 22) 1425-1430
5. Becker R.C. Emerging paradigms, platforms, and unifying themes in biomarker science. J Am Coll Cardiol 50 18 (2007 Oct 30) 1777-1780
6. Limet R., Sakalihassan N., and Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg 14 4 (1991 Oct) 540-548
7. Sakalihasan N., Limet R., and Defawe O.D. Abdominal aortic aneurysm. Lancet 365 9470 (2005 Apr 30) 1577-1589
8. Hance K.A., Tataria M., Ziporin S.J., Lee J.K., and Thompson R.W. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg 35 2 (2002 Feb) 254-261
9. Lindholt J.S., Heickendorff L., Henneberg E.W., and Fasting H. Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 14 1 (1997 Jul 1) 12-16
10. Lindholt J.S., Ashton H.A., Heickendorff L., and Scott R.A.P. Serum elastin peptides in the preoperative evaluation of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 22 6 (2001 Dec) 546-550
11. Petersen E., Gineitis A., Wagberg F., and Angquist K.A. Serum levels of elastin-derived peptides in patients with ruptured and asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 22 1 (2001 Jul) 48-52
12. Lindholt J.S., Heickendorff L., Vammen S., Fasting H., and Henneberg E.W. Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 21 3 (2001 Mar) 235-240
13. Satta J., Haukipuro K., Kairaluoma M.I., and Juvonen T. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. Journal of Vascular Surgery 25 5 (1997 May) 909-915
14. Treska V., and Topolcan O. Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms. Int Angiol 19 1 (2000 Mar) 64-68
15. Wilson K.A., Lindholt J.S., Hoskins P.R., Heickendorff L., Vammen S., and Bradbury A.W. The relationship between abdominal aortic aneurysm distensibility and serum markers of elastin and collagen metabolism. Eur J Vasc Endovasc Surg 21 2 (2001) 175-178
16. Claridge M.W., Hobbs S.D., Quick C.R., Day N.E., Bradbury A.W., and Wilmink A.B. ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg 28 1 (2004 Jul) 67-70
17. Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 20 3 (2000 Sep) 281-285
18. Hovsepian D.M., Ziporin S.J., Sakurai M.K., Lee J.K., Curci J.A., and Thompson R.W. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 11 10 (2000 Nov) 1345-1352
19. Eugster T., Huber A., Obeid T., Schwegler I., Gurke L., and Stierli P. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 29 4 (2005 Apr) 378-382
20. Lindholt J.S., Jorgensen B., Klitgaard N.A., and Henneberg E.W. Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 26 4 (2003 Oct) 418-422
21. Shi G.P., Sukhova G.K., Grubb A., Ducharme A., Rhode L.H., Lee R.T., et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104 9 (1999 Nov) 1191-1197
22. Lindholt J.S., Erlandsen E.J., and Henneberg E.W. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg 88 11 (2001 Nov) 1472-1475
23. Lindholt J.S., Jorgensen B., Fasting H., and Henneberg E.W. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. J Vasc Surg 34 4 (2001 Oct) 611-615
24. Lindholt J.S., Jorgensen B., Shi G.P., and Henneberg E.W. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 25 6 (2003 Jun) 546-551
25. Lindholt J.S. Activators of plasminogen and the progression of small abdominal aortic aneurysms. Ann N Y Acad Sci 1085 (2006 Nov) 139-150
26. Yamazumi K., Ojiro M., Okumura H., and Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 175 4 (1998 Apr) 297-301
27. Al-Barjas H.S., Ariens R., Grant P., and Scott J.A. Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology 57 5 (2006 Oct) 607-614
28. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjala H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 17 11 (1997 Nov) 2843-2847
29. Treska V., Topolcan O., and Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 38 11 (2000 Nov) 1161-1164
30. Treska V., Wenham P.W., Valenta J., Topolcan O., and Pecen L. Plasma endothelin levels in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 17 5 (1999) 424-428
31. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 18 (2001 May 8) 2260-2265
32. Pan J.H., Lindholt J.S., Sukhova G.K., Baugh J.A., Henneberg E.W., Bucala R., et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg 37 3 (2003 Mar) 628-635
33. Golledge J., Muller J., Shephard N., Clancy P., Smallwood L., Moran C., et al. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2006 Dec 14)
34. Moran C.S., McCann M., Karan M., Norman P., Ketheesan N., and Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 111 23 (2005 Jun 14) 3119-3125
35. Norman P., Spencer C.A., Lawrence-Brown M.M., and Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 110 7 (2004 Aug 17) 862-866
36. Lindholt J.S., Heegaard N.H.H., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. Smoking, but not lipids, lipoprotein (a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 21 1 (2001) 51-56
37. Vainas T., Stassen F.R., de G.R., Twiss E.L., Herngreen S.B., Welten R.J., et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42 2 (2005 Aug) 243-251
38. Domanovits H., Schillinger M., Mullner M., Holzenbein T., Janata K., Bayegan K., et al. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis 163 2 (2002 Aug) 297-302
39. Brunelli T., Prisco D., Fedi S., Rogolino A., Farsi A., Marcucci R., et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 32 3 (2000 Sep) 531-536
40. Halazun K.J., Bofkin K.A., Asthana S., Evans C., Henderson M., and Spark J.I. Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion. Eur J Vasc Endovasc Surg (2006 Dec 9)
41. Lindholt J.S., Juul S., Vammen S., Lind I., Fasting H., and Henneberg E.W. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg 86 5 (1999 May) 634-638
42. Lindholt J.S., Ashton H.A., and Scott R.A. Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg 34 2 (2001 Aug) 212-215
43. Falkensammer B., Duftner C., Seiler R., Pavlic M., Walder G., Wilflingseder D., et al. Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology. Eur J Clin Microbiol Infect Dis (2007 Jan 11)
44. Nyberg A., Skagius E., Nilsson I., Ljungh A., and Henriksson A.E. Lack of association between Chlamydophila pneumoniae seropositivity and abdominal aortic aneurysm. Vasc Endovascular Surg 41 3 (2007 Jun) 246-248